Iota-carrageenan from red seaweed inhibits SARS-CoV-2 in laboratory conditions

In a recent bioRxiv paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.

IJMS, Free Full-Text

Nutraceuticals, Free Full-Text

Viruses, Free Full-Text

Exploring algae and cyanobacteria as a promising natural source of

Biosensors, Free Full-Text

In vitro inhibition of SARS-CoV-2 Infection by dry algae powders

Iota-Carrageenan is a potent inhibitor of rhinovirus infection

Carrageenan nasal spray may double the rate of recovery from

Marine resources could be promising drug candidates against SARS

Carrageenan - an overview

Iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell

The antiviral activity of iota-, kappa-, and lambda-carrageenan

Marine Drugs, Free Full-Text

Stresses, Free Full-Text